Congress Programme

Day 3 June 5

Time	Session

07:30 08:30	Registration
08:30 10:00	Plenary Session 4: Curative Therapies in Sickle Cell Disease Alexis Thompson Co-Chair Nosa Bazuaye Co-Chair Allogeneic transplantation for sickle cell disease Prof Adetola Kassim Speaker Gene therapy and gene editing therapy for sickle cell disease Alexis Thompson Speaker Access to curative therapies in low- and middle-income countries Nosa Bazuaye Speaker
10:00 10:30	Break
10:30 12:00	Parallel Session 13: Using Technology to Advance Sickle Cell Disease Diagnosis and Care Patrick McGann Co-Chair Umut Gurkan Co-Chair Cerebrovascular complications in sickle cell disease Dr Fenella Kirkham Co-Chair	Parallel Session 14: Stigma of Sickle Cell Disease Kofi Anie Co-Chair Prof Biree Andemarian Co-Chair Multi-disciplinary and Global Overview of Stigma in Sickle Cell Disease Kofi Anie Speaker Case Presentation Prof Biree Andemarian Speaker Global Perspectives on Stigma in Sickle Cell Disease Panel Discussion		Parallel Session 15: Preventive Care for Sickle Cell Disease in Sub-Saharan Countries and India Dipty Jain Co-Chair Prof Dapa Diallo Co-Chair Integrating sickle cell disease care into India's primary health system Dr Manisha Madkaikar Speaker Infection prevention and vaccination: Reducing childhood mortality Dipty Jain Speaker Mrs vinita Srivastava Speaker Hydroxyurea access and utilization in sub-Saharan countries Prof Dapa Diallo Speaker
12:00 13:00	Lunch		Poster Sessions
13:30 14:30	Symposium 5: Pharma Sponsored Symposium Novartis Pharmaceuticals
14:30 16:00	Oral Abstracts Top Abstracts - Six Abstracts Prof Kunle Adekile Co-Chair Prof Najibah Galadanci Co-Chair
16:00 16:30	Break
16:30 18:00	Parallel Session 16: Quality of Life in Sickle Cell Disease: What Matters for Mental Health and Well-being? Dr Nchangwi Syntia Munung Co-Chair Marsha Treadwell Co-Chair From Stigma to Support: Transforming the Lives of Sickle Cell Warriors Through Resources Lewis Hsu Speaker From Surviving to Thriving: Empowering Patients as Co-Creators of Personalized and Culturally Relevant Sickle Cell Solutions Prof Okocha E Chide Speaker Resilience Isn’t Enough: Bridging the Gap Between Sickle Cell Warriors and the Systems That Shape Their Quality of Life Christelle Salomon Speaker	Parallel Session 17: SickleInAfrica – Registry and Standards of Care		Parallel Session 18: Animal Models of Sickle Cell Disease David Archer Co-Chair Prof Solomon Ofori-Acquah Co-Chair Overview of transgenic sickle cell mouse models for drug development David Archer Speaker Novel interventions to target sickle cell pain: preclinical evidence from sickle cell mice Kalpna Gupta Speaker In vivo evaluation of novel biologics for prevention and treatment of multi-system tissue damage in sickle cell disease Prof Solomon Ofori-Acquah Speaker
18:00 19:00	Symposium 6: Global Gene Therapy Initiative Prof Julie Makani Speaker Ms Jennifer Adair Chair